FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953556687> ?p ?o ?g. }

• W2953556687 endingPage "4489" @default.
• W2953556687 startingPage "4489" @default.
• W2953556687 abstract "Abstract Background: Colorectal cancer (CRC) is the 4th most common cancer in the US, and the liver is the most common site of metastatic disease. Immune checkpoint inhibitor therapy has not been successful in achieving a clinical response in most patients with CRC liver metastases (CRCLM). The liver is known to induce tolerance to foreign antigens as a result of immunosuppressive cytokines including IL-10. We hypothesized that blockade of IL-10 signaling in CRCLM would potentiate tumor infiltrating lymphocyte (TIL)-mediated tumor cell death. Methods: We performed single-cell RNA sequencing (scRNAseq) of CRCLM using the 10x platform to evaluate for expression of IL-10 or IL-10 receptor (IL-10R) RNA within the tumor (n=8). To confirm if the IL-10R protein was present within the tumor microenvironment (TME), we also performed immunohistochemistry (IHC) (n=3). In order to study the functional effects of IL-10 blockade, we utilized a tumor slice culture (TSC) model, which allows for the study of cancers with their intact TME including immune cells. For TSCs, cores (6 mm diameter) were taken from freshly resected sterile human CRCLM and cut to 250 µm thick slices using a vibratome (n=3). Duplicate slices were treated with either IgG control or anti-IL-10 monoclonal antibodies and cultured for up to 6 days. To evaluate for histological evidence of necrosis and cell apoptosis within the tumor slice, we stained slides with either hematoxylin and eosin (H&E) or cleaved-Caspase-3 (CC3). To gain insight into the activation state of TIL after treatment, we measured levels of cytokines within the culture supernatants. Results: We found by scRNAseq that that IL-10 was expressed by a subset of tumor-associated macrophages, and IL-10R was expressed by both CD4+ and CD8+ T cells as well as macrophages. We confirmed that IL-10R protein was present within the CRCLM TME by IHC, and IL-10R expression was distributed throughout the stroma in non-tumor cells. In TSC treated with anti-IL-10 antibody, CC3+ cells were found to be 82.8% of total cells, compared to 36.1% of control (p = 1 x 10-6) at day 6. These findings were consistent across all human tumor samples treated with IL-10 blockade versus control at all time points examined. Furthermore, IL-10 blockade led to histologic evidence of generalized necrosis compared to an intact TME seen in the control group. Analysis of cytokines released into the media confirmed that IL-10 was present in controls, but absent in slices blocked with anti-IL-10 antibody. We also found increased levels of granzyme B, IL-2, GM-CSF, and IL-18, as well as a reduction in the immune checkpoint receptor TIM3, after one day of IL-10 blockade in culture. Conclusion: Treatment of human CRCLM TSCs with anti-IL-10 antibody leads to a marked increase in immune-mediated cell death within the tumor. Our data suggest that IL-10 serves as a critical regulator of anti-tumor immunity in the CRCLM TME and may serve as an important immunotherapeutic target. Citation Format: Kevin M. Sullivan, Xiuyun Jiang, Yongwoo David Seo, Heidi L. Kenerson, Xiaowei Yan, Chris Lausted, Changting Meng, Neda Jabbari, Kevin P. Labadie, Sara K. Daniel, Qiang Tian, Teresa S. Kim, Raymond S. Yeung, Venu G. Pillarisetty. IL-10 blockade reactivates antitumor immunity in human colorectal cancer liver metastases [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4489." @default.
• W2953556687 created "2019-07-12" @default.
• W2953556687 creator A5003573307 @default.
• W2953556687 creator A5006150283 @default.
• W2953556687 creator A5016948087 @default.
• W2953556687 creator A5017655644 @default.
• W2953556687 creator A5025523782 @default.
• W2953556687 creator A5037321451 @default.
• W2953556687 creator A5037538576 @default.
• W2953556687 creator A5049155325 @default.
• W2953556687 creator A5053310544 @default.
• W2953556687 creator A5055046842 @default.
• W2953556687 creator A5057876282 @default.
• W2953556687 creator A5072866393 @default.
• W2953556687 creator A5073658575 @default.
• W2953556687 creator A5089280949 @default.
• W2953556687 date "2019-07-01" @default.
• W2953556687 modified "2023-09-27" @default.
• W2953556687 title "Abstract 4489: IL-10 blockade reactivates antitumor immunity in human colorectal cancer liver metastases" @default.
• W2953556687 doi "https://doi.org/10.1158/1538-7445.am2019-4489" @default.
• W2953556687 hasPublicationYear "2019" @default.
• W2953556687 type Work @default.
• W2953556687 sameAs 2953556687 @default.
• W2953556687 citedByCount "1" @default.
• W2953556687 countsByYear W29535566872021 @default.
• W2953556687 crossrefType "journal-article" @default.
• W2953556687 hasAuthorship W2953556687A5003573307 @default.
• W2953556687 hasAuthorship W2953556687A5006150283 @default.
• W2953556687 hasAuthorship W2953556687A5016948087 @default.
• W2953556687 hasAuthorship W2953556687A5017655644 @default.
• W2953556687 hasAuthorship W2953556687A5025523782 @default.
• W2953556687 hasAuthorship W2953556687A5037321451 @default.
• W2953556687 hasAuthorship W2953556687A5037538576 @default.
• W2953556687 hasAuthorship W2953556687A5049155325 @default.
• W2953556687 hasAuthorship W2953556687A5053310544 @default.
• W2953556687 hasAuthorship W2953556687A5055046842 @default.
• W2953556687 hasAuthorship W2953556687A5057876282 @default.
• W2953556687 hasAuthorship W2953556687A5072866393 @default.
• W2953556687 hasAuthorship W2953556687A5073658575 @default.
• W2953556687 hasAuthorship W2953556687A5089280949 @default.
• W2953556687 hasConcept C121608353 @default.
• W2953556687 hasConcept C125473707 @default.
• W2953556687 hasConcept C126322002 @default.
• W2953556687 hasConcept C142724271 @default.
• W2953556687 hasConcept C170493617 @default.
• W2953556687 hasConcept C17991360 @default.
• W2953556687 hasConcept C190283241 @default.
• W2953556687 hasConcept C203014093 @default.
• W2953556687 hasConcept C204232928 @default.
• W2953556687 hasConcept C2776107976 @default.
• W2953556687 hasConcept C2777701055 @default.
• W2953556687 hasConcept C2778326572 @default.
• W2953556687 hasConcept C2778468042 @default.
• W2953556687 hasConcept C2778690821 @default.
• W2953556687 hasConcept C2780851360 @default.
• W2953556687 hasConcept C502942594 @default.
• W2953556687 hasConcept C526805850 @default.
• W2953556687 hasConcept C55493867 @default.
• W2953556687 hasConcept C71924100 @default.
• W2953556687 hasConcept C74172505 @default.
• W2953556687 hasConcept C86803240 @default.
• W2953556687 hasConcept C8891405 @default.
• W2953556687 hasConceptScore W2953556687C121608353 @default.
• W2953556687 hasConceptScore W2953556687C125473707 @default.
• W2953556687 hasConceptScore W2953556687C126322002 @default.
• W2953556687 hasConceptScore W2953556687C142724271 @default.
• W2953556687 hasConceptScore W2953556687C170493617 @default.
• W2953556687 hasConceptScore W2953556687C17991360 @default.
• W2953556687 hasConceptScore W2953556687C190283241 @default.
• W2953556687 hasConceptScore W2953556687C203014093 @default.
• W2953556687 hasConceptScore W2953556687C204232928 @default.
• W2953556687 hasConceptScore W2953556687C2776107976 @default.
• W2953556687 hasConceptScore W2953556687C2777701055 @default.
• W2953556687 hasConceptScore W2953556687C2778326572 @default.
• W2953556687 hasConceptScore W2953556687C2778468042 @default.
• W2953556687 hasConceptScore W2953556687C2778690821 @default.
• W2953556687 hasConceptScore W2953556687C2780851360 @default.
• W2953556687 hasConceptScore W2953556687C502942594 @default.
• W2953556687 hasConceptScore W2953556687C526805850 @default.
• W2953556687 hasConceptScore W2953556687C55493867 @default.
• W2953556687 hasConceptScore W2953556687C71924100 @default.
• W2953556687 hasConceptScore W2953556687C74172505 @default.
• W2953556687 hasConceptScore W2953556687C86803240 @default.
• W2953556687 hasConceptScore W2953556687C8891405 @default.
• W2953556687 hasIssue "13_Supplement" @default.
• W2953556687 hasLocation W29535566871 @default.
• W2953556687 hasOpenAccess W2953556687 @default.
• W2953556687 hasPrimaryLocation W29535566871 @default.
• W2953556687 hasRelatedWork W1988832250 @default.
• W2953556687 hasRelatedWork W2153718647 @default.
• W2953556687 hasRelatedWork W2791673886 @default.
• W2953556687 hasRelatedWork W2938706471 @default.
• W2953556687 hasRelatedWork W3023901788 @default.
• W2953556687 hasRelatedWork W3096715224 @default.
• W2953556687 hasRelatedWork W3200807512 @default.
• W2953556687 hasRelatedWork W3211097582 @default.
• W2953556687 hasRelatedWork W3217412908 @default.
• W2953556687 hasRelatedWork W4281389645 @default.

• next